e-Therapeutics plc announced that Professor Malcolm Young is standing down as Chief Executive Officer with immediate effect and has resigned as a director of the company. Professor Young has agreed to be available to provide occasional assistance to the Board for the next six months.
e-therapeutics plc London S.E.
Equities
ETX
GB00B2823H99
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9 GBX | -6.74% | -.--% | +9.22% |
1st Jan change | Capi. | |
---|---|---|
+43.36% | 5.46TCr | |
-5.31% | 3.99TCr | |
+14.75% | 2.69TCr | |
-12.56% | 2.62TCr | |
-22.45% | 1.88TCr | |
+25.12% | 1.22TCr | |
+0.04% | 1.22TCr | |
+26.04% | 1.19TCr | |
-11.83% | 1.07TCr |
- Stock Market
- Equities
- ETXPF Stock
- ETX Stock
- News e-therapeutics plc
- E-Therapeutics plc Announces Resignation of Malcolm Young as Chief Executive Officer and Director